94 related articles for article (PubMed ID: 3194851)
1. C cell adenoma of the thyroid: a rare but distinct clinical entity.
Kodama T; Okamoto T; Fujimoto Y; Obara T; Ito Y; Aiba M; Hirayama A
Surgery; 1988 Dec; 104(6):997-1003. PubMed ID: 3194851
[TBL] [Abstract][Full Text] [Related]
2. A case of calcitonin producing adenoma of the thyroid.
Kodama T; Tamura M; Kanaji Y; Ito Y; Obara T; Fujimoto Y; Hirayama A
Endocrinol Jpn; 1984 Feb; 31(1):63-70. PubMed ID: 6203728
[TBL] [Abstract][Full Text] [Related]
3. Occurrence of calcitonin, somatostatin-like immunoreactivity, and carcinoembryonic antigen in two sisters suffering from familial thyroid medullary carcinoma.
Bethge N; Ahuja S; Diel F
Exp Clin Endocrinol; 1986 Dec; 88(3):365-72. PubMed ID: 2881797
[TBL] [Abstract][Full Text] [Related]
4. Demonstration of calcitonin and carcinoembryonic antigen (CEA) in medullary carcinoma of the thyroid (MCT) by immunoperoxidase technique.
Talerman A; Lindeman J; Kievit-Tyson PA; Dröge-Droppert C
Histopathology; 1979 Nov; 3(6):503-10. PubMed ID: 389771
[TBL] [Abstract][Full Text] [Related]
5. Relationship of tissue carcinoembryonic antigen and calcitonin to tumor virulence in medullary thyroid carcinoma. An immunohistochemical study in early, localized, and virulent disseminated stages of disease.
Mendelsohn G; Wells SA; Baylin SB
Cancer; 1984 Aug; 54(4):657-62. PubMed ID: 6378353
[TBL] [Abstract][Full Text] [Related]
6. Pancreas cancer-associated antigen (PCAA) in medullary thyroid carcinoma.
Ueno K; Kobayashi T; Shimano T; Matsuura N; Monden T; Takeda T; Tomita N; Mori T
Med J Osaka Univ; 1994 Sep; 43(1-4):17-21. PubMed ID: 7609706
[TBL] [Abstract][Full Text] [Related]
7. Calcitonin, carcinoembryonic antigen and neuron-specific enolase in medullary thyroid carcinoma.
Lloyd RV; Sisson JC; Marangos PJ
Cancer; 1983 Jun; 51(12):2234-9. PubMed ID: 6342746
[TBL] [Abstract][Full Text] [Related]
8. Medullary differentiation of anaplastic thyroid carcinoma.
Nieuwenhuijzen Kruseman AC; Bosman FT; van Bergen Henegouw JC; Cramer-Knijnenburg G; Brutel de la Riviere G
Am J Clin Pathol; 1982 May; 77(5):541-7. PubMed ID: 6177234
[TBL] [Abstract][Full Text] [Related]
9. Mixed medullary-follicular carcinoma of the thyroid gland: a clinicopathologic variant of medullary thyroid carcinoma.
Mizukami Y; Nonomura A; Michigishi T; Noguchi M; Ishizaki T
Mod Pathol; 1996 Jun; 9(6):631-5. PubMed ID: 8782199
[TBL] [Abstract][Full Text] [Related]
10. Medullary carcinoma of the thyroid gland: an encapsulated variant resembling the hyalinizing trabecular (paraganglioma-like) adenoma of thyroid.
Huss LJ; Mendelsohn G
Mod Pathol; 1990 Sep; 3(5):581-5. PubMed ID: 2235983
[TBL] [Abstract][Full Text] [Related]
11. Familial and sporadic medullary thyroid carcinoma: clinical and immunohistological findings.
Ekblom M; Välimäki M; Pelkonen R; Jansson R; Sivula A; Franssila K
Q J Med; 1987 Nov; 65(247):899-910. PubMed ID: 2901773
[TBL] [Abstract][Full Text] [Related]
12. C-cell hyperplasia accompanying thyroid diseases other than medullary carcinoma: an immunocytochemical study by means of antibodies to calcitonin and somatostatin.
Scopsi L; Di Palma S; Ferrari C; Holst JJ; Rehfeld JF; Rilke F
Mod Pathol; 1991 May; 4(3):297-304. PubMed ID: 1676840
[TBL] [Abstract][Full Text] [Related]
13. [Prognostic values of the doubling time of serum carcinoembryonic antigen and calcitonin levels in medullary thyroid carcinoma].
Miyauchi A; Onishi T; Matsuzuka F; Hirai K; Kuma K; Takai S; Nakamoto K; Nakamura K; Nanjo S; Maeda M
Gan No Rinsho; 1986 Oct; 32(12):1519-24. PubMed ID: 3783976
[TBL] [Abstract][Full Text] [Related]
14. Carcinoembryonic antigen and calcitonin as markers of malignancy in medullary thyroid carcinoma.
Cox CE; VanVickle J; Froome LC; Mendelsohn G; Baylin SB; Wells SA
Surg Forum; 1979; 30():120-1. PubMed ID: 395674
[No Abstract] [Full Text] [Related]
15. Oxyphil and squamous variants of medullary thyroid carcinoma.
Dominguez-Malagon H; Delgado-Chavez R; Torres-Najera M; Gould E; Albores-Saavedra J
Cancer; 1989 Mar; 63(6):1183-8. PubMed ID: 2917321
[TBL] [Abstract][Full Text] [Related]
16. Measurement of serum PDN-21 (Katacalcin) levels by radioimmunoassay in patients with various thyroid diseases.
Takami H
Exp Clin Endocrinol; 1994; 102(5):370-3. PubMed ID: 7867699
[TBL] [Abstract][Full Text] [Related]
17. Calcitonin and carcinoembryonic antigen in poorly differentiated follicular carcinoma.
Calmettes C; Caillou B; Moukhtar MS; Milhaud G; Gerard-Marchant R
Cancer; 1982 Jun; 49(11):2342-8. PubMed ID: 7042069
[TBL] [Abstract][Full Text] [Related]
18. An immunohistochemical study in thyroid cancer.
Beltrami CA; Barbatelli G; Criante P; Paliaga A; Amadi CE
Appl Pathol; 1987; 5(4):229-45. PubMed ID: 2446641
[TBL] [Abstract][Full Text] [Related]
19. Plasma and tumor levels of somatostatin (SRIF) and somatostatin immunochemistry in medullary thyroid carcinoma: apparently discrepant preliminary results.
Franc B; Chayvialle JA; Modigliani E; Calmettes C; Caillou B; Dutrieux-Berger N; Houdent C; Kujas M
Henry Ford Hosp Med J; 1987; 35(2-3):147-8. PubMed ID: 2891647
[No Abstract] [Full Text] [Related]
20. Lung carcinoma metastatic to microfollicular adenoma of the thyroid. A case report.
Mizukami Y; Saito K; Nonomura A; Michigishi T; Hashimoto T; Nakanuma Y; Matsubara F; Takasakura E
Acta Pathol Jpn; 1990 Aug; 40(8):602-8. PubMed ID: 2239314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
